Of particular interest are the results showing that, in addition to the robust activation of LMP, the combination of chloroquine and triarylpyridine compounds triggers massive cell death in a variety of cancer cells, including HeLa, U2OS and A549 cell lines, as well as PDX cells from lung cancer patients. Here, PDLIM7 is linked to cancer.